Ikena Oncology, Inc.IKNANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-17.2%
5Y CAGR-40.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-17.2%/yr
vs -73.0%/yr prior
5Y CAGR
-40.9%/yr
Recent acceleration
Acceleration
+55.8pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 42.01 | -84.5% |
| 2024 | 271.35 | +151.9% |
| 2023 | 107.71 | +45.6% |
| 2022 | 73.96 | -57.7% |
| 2021 | 174.71 | -70.1% |
| 2020 | 584.21 | -41.6% |
| 2019 | 1001.01 | -92.8% |
| 2018 | 13905.94 | - |